Predicting Cross-Reactivity and Antigen Specificity of T Cell Receptors

Adaptive immune recognition is mediated by specific interactions between heterodimeric T cell receptors (TCRs) and their cognate peptide-MHC (pMHC) ligands, and the methods to accurately predict TCR:pMHC interaction would have profound clinical, therapeutic and pharmaceutical applications. Herein, we review recent developments in predicting cross-reactivity and antigen specificity of TCR recognition. We discuss current experimental and computational approaches to investigate cross-reactivity and antigen-specificity of TCRs and highlight how integrating kinetic, biophysical and structural features may offer valuable insights in modeling immunogenicity. We further underscore the close inter-relationship of these two interconnected notions and the need to investigate each in the light of the other for a better understanding of T cell responsiveness for the effective clinical applications.

[1]  John Nguyen,et al.  Human CD8+ T Cells Exhibit a Shared Antigen Threshold for Different Effector Responses , 2020, The Journal of Immunology.

[2]  R. Bourgon,et al.  Mutation position is an important determinant for predicting cancer neoantigens , 2020, The Journal of experimental medicine.

[3]  Mark M. Davis,et al.  Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer’s disease , 2020, Nature.

[4]  A. Pomés,et al.  Cross‐reactivity in allergy: A double‐edged sword , 2020, Allergy.

[5]  Catherine J. Wu,et al.  Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers , 2019, Clinical Cancer Research.

[6]  Mark M. Davis,et al.  In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls , 2019, Nature Communications.

[7]  Katherine Luzuriaga,et al.  CDR3α drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection , 2019, PLoS pathogens.

[8]  J. Castle,et al.  TCR Fingerprinting and Off-Target Peptide Identification , 2019, Front. Immunol..

[9]  M. Nishimura,et al.  Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy , 2019, Cancer Immunology, Immunotherapy.

[10]  Andrew K. Sewell,et al.  VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium , 2019, Nucleic Acids Res..

[11]  Sara R. Selitsky,et al.  Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes , 2019, Cancer Immunology Research.

[12]  J. Devlin,et al.  Structure Based Prediction of Neoantigen Immunogenicity , 2019, Front. Immunol..

[13]  Paolo Marcatili,et al.  T-Cell Receptor Cognate Target Prediction Based on Paired α and β Chain Sequence and Structural CDR Loop Similarities , 2019, Front. Immunol..

[14]  S. Elledge,et al.  T-Scan: A Genome-wide Method for the Systematic Discovery of T Cell Epitopes , 2019, Cell.

[15]  S. Mallal,et al.  Identification of drug-specific public TCR driving severe cutaneous adverse reactions , 2019, Nature Communications.

[16]  Adrian W. Briggs,et al.  Single T Cell Sequencing Demonstrates the Functional Role of αβ TCR Pairing in Cell Lineage and Antigen Specificity , 2019, Front. Immunol..

[17]  A. Bentzen,et al.  T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation , 2019, Immuno-oncology technology.

[18]  Ragul Gowthaman,et al.  TCR3d: The T cell receptor structural repertoire database , 2019, Bioinform..

[19]  M. Pogorelyy,et al.  A Framework for Annotation of Antigen Specificities in High-Throughput T-Cell Repertoire Sequencing Studies , 2019, bioRxiv.

[20]  Thierry Mora,et al.  Detecting T cell receptors involved in immune responses from single repertoire snapshots , 2018, bioRxiv.

[21]  I. Springer,et al.  Prediction of Specific TCR-Peptide Binding From Large Dictionaries of TCR-Peptide Pairs , 2019, bioRxiv.

[22]  Howard Y. Chang,et al.  Clonal replacement of tumor-specific T cells following PD-1 blockade , 2019, bioRxiv.

[23]  H. Yotsuyanagi,et al.  Quantitative Prediction of the Landscape of T Cell Epitope Immunogenicity in Sequence Space , 2019, Front. Immunol..

[24]  Inimary T. Toby,et al.  Biophysicochemical Motifs in T-cell Receptor Sequences Distinguish Repertoires from Tumor-Infiltrating Lymphocyte and Adjacent Healthy Tissue. , 2019, Cancer research.

[25]  F. Obermair,et al.  Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors , 2019, Nature Immunology.

[26]  Y. Zhang,et al.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  P. Bradley,et al.  Using T Cell Receptor Repertoires to Understand the Principles of Adaptive Immune Recognition. , 2019, Annual review of immunology.

[28]  Jocelyn T. Kim,et al.  T cell antigen discovery via trogocytosis , 2019, Nature Methods.

[29]  J. Heath,et al.  T cell antigen discovery via Signaling and Antigen presenting Bifunctional Receptors , 2019, Nature Methods.

[30]  C. Bailey-Kellogg,et al.  Balancing sensitivity and specificity in distinguishing TCR groups by CDR sequence similarity , 2019, bioRxiv.

[31]  V. Warnault,et al.  Signaling , 2018, Modeling Strategic Behavior.

[32]  Sol Efroni,et al.  Network Representation of T-Cell Repertoire— A Novel Tool to Analyze Immune Response to Cancer Formation , 2018, Front. Immunol..

[33]  D. Roelen,et al.  Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome , 2018, Front. Immunol..

[34]  T. P. Riley,et al.  The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics. , 2018, Seminars in cell & developmental biology.

[35]  Joseph P. Sanderson,et al.  Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate , 2018, Oncoimmunology.

[36]  D. Klenerman,et al.  A cell topography-based mechanism for ligand discrimination by the T cell receptor , 2019, Proceedings of the National Academy of Sciences.

[37]  Morten Nielsen,et al.  T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide–MHC complexes , 2018, Nature Biotechnology.

[38]  Weiping Jia,et al.  High-throughput determination of the antigen specificities of T cell receptors in single cells , 2018, Nature Biotechnology.

[39]  M. Nielsen,et al.  NetTCR: sequence-based prediction of TCR binding to peptide-MHC complexes using convolutional neural networks , 2018, bioRxiv.

[40]  Kris Laukens,et al.  On the viability of unsupervised T-cell receptor sequence clustering for epitope preference , 2018, Bioinform..

[41]  K. Garcia,et al.  T cell receptor cross-reactivity expanded by dramatic peptide/MHC adaptability , 2018, Nature Chemical Biology.

[42]  Mikhail Shugay,et al.  Exploring the pre-immune landscape of antigen-specific T cells , 2018, Genome Medicine.

[43]  C. Clouser,et al.  Mice developing mammary tumors evolve T cell sequences shared with human breast cancer patients , 2018, bioRxiv.

[44]  M. Pagani,et al.  Single Cell T Cell Receptor Sequencing: Techniques and Future Challenges , 2018, Front. Immunol..

[45]  K. Christopher Garcia,et al.  Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro , 2018, Proceedings of the National Academy of Sciences.

[46]  William A. Goddard,et al.  Isolation of a Structural Mechanism for Uncoupling T Cell Receptor Signaling from Peptide-MHC Binding , 2018, Cell.

[47]  Sri H. Ramarathinam,et al.  Identification of Native and Posttranslationally Modified HLA‐B*57:01‐Restricted HIV Envelope Derived Epitopes Using Immunoproteomics , 2018, Proteomics.

[48]  J. Gartner,et al.  Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer , 2018, Nature Medicine.

[49]  Charlotte M. Deane,et al.  pyHVis3D: visualising molecular simulation deduced H-bond networks in 3D: application to T-cell receptor interactions , 2018, Bioinform..

[50]  R. Hagedoorn,et al.  Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  William S. DeWitt,et al.  Human T cell receptor occurrence patterns encode immune history, genetic background, and receptor specificity , 2018, bioRxiv.

[52]  Y. Wang,et al.  Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[53]  Hiroshi Wako,et al.  A study of CDR3 loop dynamics reveals distinct mechanisms of peptide recognition by T‐cell receptors exhibiting different levels of cross‐reactivity , 2018, Immunology.

[54]  A. N. Davydov,et al.  Comparative analysis of murine T‐cell receptor repertoires , 2018, Immunology.

[55]  D. Levey.  Recognition , 2017, The Harps that Once....

[56]  D. Frishman,et al.  Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues , 2017, BMC Cancer.

[57]  Junghyo Jo,et al.  Broad cross-reactivity of the T-cell repertoire achieves specific and sufficiently rapid target searching. , 2017, Journal of theoretical biology.

[58]  Purvesh Khatri,et al.  Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes , 2017, Cell.

[59]  Cédric R. Weber,et al.  Computational Strategies for Dissecting the High-Dimensional Complexity of Adaptive Immune Repertoires , 2017, Front. Immunol..

[60]  Z. Szallasi,et al.  An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes , 2017, Front. Immunol..

[61]  A. Levine,et al.  A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy , 2017, Nature.

[62]  Charlotte M. Deane,et al.  STCRDab: the structural T-cell receptor database , 2017, Nucleic Acids Res..

[63]  Lydia E. Kavraki,et al.  Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy , 2017, Front. Immunol..

[64]  Jaime Prilusky,et al.  McPAS‐TCR: a manually curated catalogue of pathology‐associated T cell receptor sequences , 2017, Bioinform..

[65]  Vanessa M. Peterson,et al.  Multiplexed quantification of proteins and transcripts in single cells , 2017, Nature Biotechnology.

[66]  H. Swerdlow,et al.  Large-scale simultaneous measurement of epitopes and transcriptomes in single cells , 2017, Nature Methods.

[67]  Charles H. Yoon,et al.  An immunogenic personal neoantigen vaccine for patients with melanoma , 2017, Nature.

[68]  P. Bradley,et al.  Quantifiable predictive features define epitope-specific T cell receptor repertoires , 2017, Nature.

[69]  Alessandro Sette,et al.  Identifying specificity groups in the T cell receptor repertoire , 2017, Nature.

[70]  Y. Wang,et al.  Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells , 2017, Cancer Immunology, Immunotherapy.

[71]  William S. DeWitt,et al.  Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire , 2017, Nature Genetics.

[72]  Sai T Reddy,et al.  Advanced Methodologies in High-Throughput Sequencing of Immune Repertoires. , 2017, Trends in biotechnology.

[73]  Dario Ghersi,et al.  Broad TCR Repertoire And Diverse Structural Solutions To Recognition Of An Immunodominant CD8 T Cell Epitope , 2017, Nature Structural &Molecular Biology.

[74]  Benjamin Chain,et al.  High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities , 2017, Briefings Bioinform..

[75]  Yuxin Sun,et al.  Feature selection using a one dimensional naïve Bayes’ classifier increases the accuracy of support vector machine classification of CDR3 repertoires , 2017, Bioinform..

[76]  J. Burrows,et al.  Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis , 2017, Clinical & translational immunology.

[77]  B. Evavold,et al.  Low-affinity CD4+ T cells are major responders in the primary immune response , 2016, Nature Communications.

[78]  Charlotte M. Deane,et al.  The contribution of major histocompatibility complex contacts to the affinity and kinetics of T cell receptor binding , 2016, Scientific Reports.

[79]  N. Singh,et al.  Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex* , 2016, The Journal of Biological Chemistry.

[80]  Zhiping Weng,et al.  A generalized framework for computational design and mutational scanning of T-cell receptor binding interfaces. , 2016, Protein engineering, design & selection : PEDS.

[81]  Z. Szallasi,et al.  Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes , 2016, Nature Biotechnology.

[82]  Jun S. Liu,et al.  Comprehensive analyses of tumor immunity: implications for cancer immunotherapy , 2016, Genome Biology.

[83]  Andrew K. Sewell,et al.  Hydrophobic CDR3 residues promote the development of self-reactive T cells , 2016, Nature Immunology.

[84]  A. Sewell,et al.  Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity , 2016, The Journal of clinical investigation.

[85]  M. Nishimura,et al.  Strategies to genetically engineer T cells for cancer immunotherapy , 2016, Cancer Immunology, Immunotherapy.

[86]  Klaus Schulten,et al.  All-Atom Molecular Dynamics of Virus Capsids as Drug Targets , 2016, The journal of physical chemistry letters.

[87]  S. Brouard,et al.  Cross-Reactivity of TCR Repertoire: Current Concepts, Challenges, and Implication for Allotransplantation , 2016, Front. Immunol..

[88]  Anneliese O. Speak,et al.  T cell fate and clonality inference from single cell transcriptomes , 2016, Nature Methods.

[89]  H. Wedemeyer,et al.  Hepatitis C virus infection from the perspective of heterologous immunity. , 2016, Current opinion in virology.

[90]  Bent K. Jakobsen,et al.  Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy , 2016, Scientific Reports.

[91]  Mikhail Pogorelyy,et al.  VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires , 2015, PLoS Comput. Biol..

[92]  T. Wittkop,et al.  Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor Sequencing , 2015, PloS one.

[93]  David M. Kranz,et al.  Structural interplay between germline and adaptive recognition determines TCR-peptide-MHC cross-reactivity , 2015, Nature Immunology.

[94]  Marialva Sinigaglia,et al.  Improved structural method for T-cell cross-reactivity prediction. , 2015, Molecular immunology.

[95]  B. Evavold,et al.  Lower Affinity T Cells are Critical Components and Active Participants of the Immune Response , 2015, Front. Immunol..

[96]  R. Welsh,et al.  Evaluation of non-reciprocal heterologous immunity between unrelated viruses. , 2015, Virology.

[97]  Charlotte M. Deane,et al.  Rapid, Precise, and Reproducible Prediction of Peptide-MHC Binding Affinities from Molecular Dynamics That Correlate Well with Experiment. , 2015, Journal of chemical theory and computation.

[98]  Dmitrij Frishman,et al.  Expitope: a web server for epitope expression , 2015, Bioinform..

[99]  Sri Krishna,et al.  TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes , 2015, Proceedings of the National Academy of Sciences.

[100]  J. Wolchok,et al.  Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[101]  Timothy Cardozo,et al.  Specific Increase in Potency via Structure-Based Design of a TCR , 2014, The Journal of Immunology.

[102]  John Shawe-Taylor,et al.  Tracking global changes induced in the CD4 T-cell receptor repertoire by immunization with a complex antigen using short stretches of CDR3 protein sequence , 2014, bioRxiv.

[103]  B. Evavold,et al.  This information is current as Molecules Triggers Calcium in T Cells Antigenic Peptides Embedded in MHC CD 8 Frequently Applied by Agonist Accumulation of Serial Forces on TCR and , 2014 .

[104]  M. Nielsen,et al.  NetTepi: an integrated method for the prediction of T cell epitopes , 2014, Immunogenetics.

[105]  Mark M. Davis,et al.  Deconstructing the Peptide-MHC Specificity of T Cell Recognition , 2014, Cell.

[106]  Cheng Zhu,et al.  Accumulation of Dynamic Catch Bonds between TCR and Agonist Peptide-MHC Triggers T Cell Signaling , 2014, Cell.

[107]  Mikhail Shugay,et al.  Distinctive properties of identical twins' TCR repertoires revealed by high-throughput sequencing , 2014, Proceedings of the National Academy of Sciences.

[108]  Omer Dushek,et al.  An induced rebinding model of antigen discrimination☆ , 2014, Trends in immunology.

[109]  Zhiping Weng,et al.  Computational Design of the Affinity and Specificity of a Therapeutic T Cell Receptor , 2014, PLoS Comput. Biol..

[110]  G. Ogg,et al.  Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⁺ T cell specificity. , 2014, Journal of immunological methods.

[111]  T. Schumacher,et al.  HLA Micropolymorphisms Strongly Affect Peptide–MHC Multimer–Based Monitoring of Antigen-Specific CD8+ T Cell Responses , 2014, The Journal of Immunology.

[112]  M. Nielsen,et al.  NetMHCstab – predicting stability of peptide–MHC‐I complexes; impacts for cytotoxic T lymphocyte epitope discovery , 2014, Immunology.

[113]  H. Dienes,et al.  Clonal Exhaustion as a Mechanism to Protect Against Severe Immunopathology and Death from an Overwhelming CD8 T Cell Response , 2013, Front. Immunol..

[114]  R. Welsh,et al.  Disparate Epitopes Mediating Protective Heterologous Immunity to Unrelated Viruses Share Peptide–MHC Structural Features Recognized by Cross-Reactive T Cells , 2013, The Journal of Immunology.

[115]  A. Sewell,et al.  T-cell Receptor (TCR)-Peptide Specificity Overrides Affinity-enhancing TCR-Major Histocompatibility Complex Interactions* , 2013, The Journal of Biological Chemistry.

[116]  Min-Sun Park,et al.  Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens. , 2013, Molecular immunology.

[117]  N. Restifo,et al.  Reassessing target antigens for adoptive T cell therapy , 2013, Nature Biotechnology.

[118]  Alessandro Sette,et al.  Properties of MHC Class I Presented Peptides That Enhance Immunogenicity , 2013, PLoS Comput. Biol..

[119]  A. Sewell,et al.  Cellular-Level Versus Receptor-Level Response Threshold Hierarchies in T-Cell Activation , 2013, Front. Immunol..

[120]  Bent K Jakobsen,et al.  Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells , 2013, Science Translational Medicine.

[121]  M. Cuendet,et al.  Structure-Based, Rational Design of T Cell Receptors , 2013, Front. Immunol..

[122]  Hong D. Chen,et al.  Anti–IFN-γ and Peptide-Tolerization Therapies Inhibit Acute Lung Injury Induced by Cross-Reactive Influenza A–Specific Memory T Cells , 2013, The Journal of Immunology.

[123]  Mark M Davis,et al.  Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. , 2013, Immunity.

[124]  A. Sewell,et al.  Peptide length determines the outcome of TCR/peptide-MHCI engagement. , 2013, Blood.

[125]  Tongguang Wang,et al.  Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy , 2013, Journal of immunotherapy.

[126]  Z. Weng,et al.  A flexible docking approach for prediction of T cell receptor–peptide–MHC complexes , 2013, Protein science : a publication of the Protein Society.

[127]  R. Mariuzza,et al.  Structural basis for self‐recognition by autoimmune T‐cell receptors , 2012, Immunological reviews.

[128]  Katherine K. Matthews,et al.  T-cell Receptor-optimized Peptide Skewing of the T-cell Repertoire Can Enhance Antigen Targeting* , 2012, The Journal of Biological Chemistry.

[129]  Andrew K. Sewell,et al.  Why must T cells be cross-reactive? , 2012, Nature Reviews Immunology.

[130]  Ravi V. Kolla,et al.  T Cell Responses to Known Allergen Proteins Are Differently Polarized and Account for a Variable Fraction of Total Response to Allergen Extracts , 2012, The Journal of Immunology.

[131]  Hau-San Wong,et al.  Towards a Mathematical Foundation of Immunology and Amino Acid Chains , 2012, ArXiv.

[132]  J. Rossjohn,et al.  Loss of Anti-Viral Immunity by Infection with a Virus Encoding a Cross-Reactive Pathogenic Epitope , 2012, PLoS pathogens.

[133]  Morten Nielsen,et al.  NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.

[134]  K. Garcia,et al.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. , 2011, Immunity.

[135]  D. Price,et al.  A Single Autoimmune T Cell Receptor Recognizes More Than a Million Different Peptides* , 2011, The Journal of Biological Chemistry.

[136]  Shinn-Ying Ho,et al.  POPISK: T-cell reactivity prediction using support vector machines and string kernels , 2011, BMC Bioinformatics.

[137]  Olivier Michielin,et al.  How T cell receptors interact with peptide‐MHCs: A multiple steered molecular dynamics study , 2011, Proteins.

[138]  E. Naumova,et al.  The Polyclonal CD8 T Cell Response to Influenza M158–66 Generates a Fully Connected Network of Cross-Reactive Clonotypes to Structurally Related Peptides: A Paradigm for Memory Repertoire Coverage of Novel Epitopes or Escape Mutants , 2011, The Journal of Immunology.

[139]  B. Baker,et al.  Conformational Melding Permits a Conserved Binding Geometry in TCR Recognition of Foreign and Self Molecular Mimics , 2011, The Journal of Immunology.

[140]  John L. Sullivan,et al.  Broad Cross-Reactive TCR Repertoires Recognizing Dissimilar Epstein-Barr and Influenza A Virus Epitopes , 2010, The Journal of Immunology.

[141]  A. Sewell,et al.  CD8 Controls T Cell Cross-Reactivity , 2010, The Journal of Immunology.

[142]  Robert C. Edgar,et al.  Search and clustering orders of magnitude faster than BLAST , 2010, Bioinform..

[143]  Sue-Jane Lin,et al.  Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoire. , 2010, The American journal of pathology.

[144]  R. Welsh,et al.  Heterologous immunity between viruses , 2010, Immunological reviews.

[145]  A. Amir,et al.  Allo-HLA reactivity of virus-specific memory T cells is common. , 2010, Blood.

[146]  L. Watkin,et al.  CD8 T Cell Cross-Reactivity Networks Mediate Heterologous Immunity in Human EBV and Murine Vaccinia Virus Infections , 2010, The Journal of Immunology.

[147]  Daniel Coombs,et al.  Dependence of T Cell Antigen Recognition on T Cell Receptor-Peptide MHC Confinement Time , 2010, Immunity.

[148]  Kurt H Piepenbrink,et al.  T cell receptor cross-reactivity directed by antigen-dependent tuning of peptide-MHC molecular flexibility. , 2009, Immunity.

[149]  J. Greenbaum,et al.  A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease , 2009, PLoS pathogens.

[150]  Abigail Wacher,et al.  Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. , 2009, Blood.

[151]  Bjoern Peters,et al.  Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1 , 2009, The Journal of Immunology.

[152]  S. Rosenberg,et al.  Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. , 2009, Blood.

[153]  W. Kast,et al.  Relationship between CD8-dependent antigen recognition, T cell functional avidity, and tumor cell recognition , 2009, Cancer Immunology, Immunotherapy.

[154]  Zhiping Weng,et al.  Structure‐based design of a T‐cell receptor leads to nearly 100‐fold improvement in binding affinity for pepMHC , 2009, Proteins.

[155]  Sri H. Ramarathinam,et al.  Phosphorylated self-peptides alter human leukocyte antigen class I-restricted antigen presentation and generate tumor-specific epitopes , 2009, Proceedings of the National Academy of Sciences.

[156]  Rainer A Böckmann,et al.  Low-affinity peptides and T-cell selection. , 2009, Trends in immunology.

[157]  D. Kranz,et al.  T‐cell receptor binding affinities and kinetics: impact on T‐cell activity and specificity , 2009, Immunology.

[158]  J. Shabanowitz,et al.  Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for presentation of transformed self , 2008, Nature Immunology.

[159]  W. Robinson,et al.  Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice , 2008, The Journal of experimental medicine.

[160]  Morten Nielsen,et al.  Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for “Holes” in the T Cell Repertoire , 2008, PloS one.

[161]  B. Walker,et al.  Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus. , 2008, The Journal of clinical investigation.

[162]  Yi Li,et al.  High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines1 , 2007, The Journal of Immunology.

[163]  Jennifer Maynard,et al.  Structural evidence for a germline-encoded T cell receptor–major histocompatibility complex interaction 'codon' , 2007, Nature Immunology.

[164]  J. Marth,et al.  Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis. , 2007, Immunity.

[165]  A. Perelson,et al.  Polyspecificity of T cell and B cell receptor recognition. , 2007, Seminars in immunology.

[166]  R. Fujinami,et al.  Pathogenic epitopes, heterologous immunity and vaccine design , 2007, Nature Reviews Microbiology.

[167]  Bjoern Peters,et al.  A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection1 , 2007, The Journal of Immunology.

[168]  M. Nishimura,et al.  Influence of human CD8 on antigen recognition by T-cell receptor-transduced cells. , 2006, Cancer research.

[169]  Phillip M Devlin,et al.  The history of the smallpox vaccine. , 2006, The Journal of infection.

[170]  H. Bui,et al.  Structural prediction of peptides binding to MHC class I molecules , 2006, Proteins.

[171]  Wuyuan Lu,et al.  Preclinical Evaluation of Synthetic −2 RANTES as a Candidate Vaginal Microbicide To Target CCR5 , 2006, Antimicrobial Agents and Chemotherapy.

[172]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[173]  A. Bertoletti,et al.  The influence of T cell cross‐reactivity on HCV‐peptide specific human T cell response , 2006, Hepatology.

[174]  Maninder Singh Setia,et al.  The role of BCG in prevention of leprosy: a meta-analysis. , 2006, The Lancet. Infectious diseases.

[175]  O. Michielin,et al.  Structural prediction of peptides bound to MHC class I. , 2006, Journal of molecular biology.

[176]  L. Watkin,et al.  Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. , 2005, The Journal of clinical investigation.

[177]  N. Hu,et al.  Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice. , 2005, Vaccine.

[178]  Bjoern Peters,et al.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[179]  Louis J. Picker,et al.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects , 2005, The Journal of experimental medicine.

[180]  N. Rufer.  Molecular tracking of antigen-specific T-cell clones during immune responses. , 2005, Current opinion in immunology.

[181]  W. Atchley,et al.  Solving the protein sequence metric problem. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[182]  F. Celada,et al.  CD8 memory T cells: cross-reactivity and heterologous immunity , 2004, Seminars in Immunology.

[183]  J. Laman,et al.  The Guillain-Barré syndrome: a true case of molecular mimicry. , 2004, Trends in immunology.

[184]  Clemencia Pinilla,et al.  A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. , 2004, Molecular immunology.

[185]  Mark M Davis,et al.  Evidence that structural rearrangements and/or flexibility during TCR binding can contribute to T cell activation. , 2003, Molecular cell.

[186]  Timothy K Starr,et al.  Positive and negative selection of T cells. , 2003, Annual review of immunology.

[187]  J. Baatz,et al.  Cross-reactivity between HLA-A2-restricted FLU-M1:58–66 and HIV p17 GAG:77–85 epitopes in HIV-infected and uninfected individuals , 2003, Journal of Translational Medicine.

[188]  Yingdong Zhao,et al.  Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL1 , 2002, The Journal of Immunology.

[189]  J. Sacchettini,et al.  A Structural Difference Limited to One Residue of the Antigenic Peptide Can Profoundly Alter the Biological Outcome of the TCR-Peptide/MHC Class I Interaction1 , 2001, The Journal of Immunology.

[190]  R. Houghten,et al.  Enhanced immune activity of cytotoxic T-lymphocyte epitope analogs derived from positional scanning synthetic combinatorial libraries. , 2001, Blood.

[191]  S. Nathenson,et al.  Altered Peptide Ligand-Mediated TCR Antagonism Can Be Modulated by a Change in a Single Amino Acid Residue Within the CDR3β of an MHC Class I-Restricted TCR1 , 2000, The Journal of Immunology.

[192]  Henrique Veiga-Fernandes,et al.  Response of naïve and memory CD8+ T cells to antigen stimulation in vivo , 2000, Nature Immunology.

[193]  K. Garcia,et al.  A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. , 2000, Immunity.

[194]  R. Inman,et al.  Molecular mimicry and autoimmunity. , 1999, The New England journal of medicine.

[195]  Yingdong Zhao,et al.  Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease , 1999, Nature Medicine.

[196]  A. Casrouge,et al.  A Direct Estimate of the Human αβ T Cell Receptor Diversity , 1999 .

[197]  J. Yewdell,et al.  Modification of Cysteine Residues In Vitro and In Vivo Affects the Immunogenicity and Antigenicity of Major Histocompatibility Complex Class I–restricted Viral Determinants , 1999, The Journal of experimental medicine.

[198]  D. Wiley,et al.  Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures. , 1999, Journal of immunology.

[199]  M. Oldstone.  Molecular mimicry and immune‐mediated diseases , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[200]  D. Mason,et al.  A very high level of crossreactivity is an essential feature of the T-cell receptor. , 1998, Immunology today.

[201]  A. Steere,et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.

[202]  R. Germain,et al.  Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. , 1998, Journal of immunology.

[203]  J. Curtsinger,et al.  CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. , 1998, Journal of immunology.

[204]  S. Rowland-Jones,et al.  Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes , 1998, Current Biology.

[205]  H Cantor,et al.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. , 1998, Science.

[206]  A. Agulnik,et al.  The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. , 1997, Immunity.

[207]  I Lasters,et al.  Computation of the binding of fully flexible peptides to proteins with flexible side chains , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[208]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.

[209]  Hans-Peter Kriegel,et al.  A Density-Based Algorithm for Discovering Clusters in Large Spatial Databases with Noise , 1996, KDD.

[210]  A. Lanzavecchia,et al.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.

[211]  A. Lanzavecchia,et al.  Serial triggering of many T-cell receptors by a few peptide–MHC complexes , 1995, Nature.

[212]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[213]  A. Leach,et al.  Ligand docking to proteins with discrete side-chain flexibility. , 1994, Journal of molecular biology.

[214]  F Gotch,et al.  Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site , 1988, The Journal of experimental medicine.

[215]  H. Scheraga,et al.  Statistical analysis of the physical properties of the 20 naturally occurring amino acids , 1985 .

[216]  M. Epstein,et al.  Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants , 1983, The Journal of experimental medicine.

[217]  M. Bevan,et al.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? , 1977, Cellular immunology.

[218]  Jeffery B. Klauda,et al.  Setting Up All-Atom Molecular Dynamics Simulations to Study the Interactions of Peripheral Membrane Proteins with Model Lipid Bilayers. , 2019, Methods in molecular biology.

[219]  C. Bailey-Kellogg,et al.  HCV epitope, homologous to multiple human protein sequences, induces a regulatory T cell response in infected patients. , 2015, Journal of hepatology.

[220]  L. Watkin,et al.  Vaccination and heterologous immunity: educating the immune system. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[221]  Jack Snoeyink,et al.  Scientific benchmarks for guiding macromolecular energy function improvement. , 2013, Methods in enzymology.

[222]  J. Gorski,et al.  Cross-reactivity of T cells and its role in the immune system. , 2012, Critical reviews in immunology.

[223]  Omer Dushek,et al.  Mechanisms for T cell receptor triggering , 2011, Nature Reviews Immunology.

[224]  J. Paulson.  Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis , 2007 .

[225]  Steven A. Frank,et al.  Immunology and Evolution of Infectious Disease , 2002 .

[226]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[227]  Minoru Kanehisa,et al.  AAindex: Amino Acid index database , 2000, Nucleic Acids Res..

[228]  B. Evavold,et al.  Low-affinity CD 4 + T cells are major responders in the primary immune response , 2022 .